1. Home
  2. FLYX vs LIXT Comparison

FLYX vs LIXT Comparison

Compare FLYX & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo flyExclusive Inc.

FLYX

flyExclusive Inc.

HOLD

Current Price

$1.63

Market Cap

97.7M

Sector

Finance

ML Signal

HOLD

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$7.21

Market Cap

107.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLYX
LIXT
Founded
2015
2005
Country
United States
United States
Employees
N/A
3
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.7M
107.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FLYX
LIXT
Price
$1.63
$7.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
295.9K
594.5K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.47
N/A
Revenue Next Year
$15.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.56
$2.45
52 Week High
$8.88
$8.38

Technical Indicators

Market Signals
Indicator
FLYX
LIXT
Relative Strength Index (RSI) 29.46 54.53
Support Level N/A $6.21
Resistance Level $2.73 $7.64
Average True Range (ATR) 0.14 0.84
MACD -0.03 -0.05
Stochastic Oscillator 12.82 53.35

Price Performance

Historical Comparison
FLYX
LIXT

About FLYX flyExclusive Inc.

flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet, which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a clinical-stage biopharmaceutical and proton cancer therapy company focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies. The company's drug product pipeline is focused on inhibitors of protein phosphatase 2A, which is used to enhance cytotoxic agents, radiation, immune checkpoint blockers and other cancer therapies. Its product is LB-100 for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer. The company operates in a single reportable segment, which consists of the development of cancer treatments.

Share on Social Networks: